RYBELSUS is contraindicated in patients with a prior serious hypersensitivity reaction to semaglutide or to any of the excipients in RYBELSUS [see Adverse Reactions (6.2)]
Healthcare providers screen for contraindications, such as a family history of thyroid cancer, MEN2, or pancreatitis, and perform essential lab tests like A1C, TSH, metabolic panels, and lipid profiles before starting treatment
Cognitive Behavioral Therapy (CBT) can be effective for tackling the psychological challenges associated with eating disorders and obesity
Education and Training : We will educate you about the medications and provide comprehensive training on how to safely administer the injections at home, ensuring you feel confident and informed
The Europe GLP-1 Receptor Agonist Market is estimated to be USD 16.84 Billion in 2025 and is projected to reach USD 78.24 Billion by 2035, growing at a CAGR of 16.59% during 20262035
This result and the enhanced survival indicate that semaglutide was repairing damage to the cells, says Dr Anastasiou